News

Filter

ESMO 2014: Roche's cobimetinib and Perjeta; Specialised Therapeutics Australia's anamorelin

ESMO 2014: Roche's cobimetinib and Perjeta; Specialised Therapeutics Australia's anamorelin

29-09-2014

Swiss drug major Roche presented positive results from a Phase III study of cobimetinib plus Zelboraf…

anamorelincobimetinibHelsinnOncologyPerjetaPharmaceuticalResearchRocheSpainSpecialised Therapeutics Australia

Ariad Pharma plans commercialization of Iclusig in Australia

Ariad Pharma plans commercialization of Iclusig in Australia

28-01-2014

US specialty pharma firm Ariad Pharmaceuticals has signed an agreement with Specialised Therapeutics…

Ariad PharmaceuticalsAsia-PacificAustraliaIclusigLicensingOncologyPharmaceuticalSpecialised Therapeutics Australia

First Ph III Abraxane trial in metastatic pancreatic cancer to report three year survival rates

First Ph III Abraxane trial in metastatic pancreatic cancer to report three year survival rates

18-01-2014

US biotech firm Celgene’s breast cancer drug, Abraxane (nanoparticle albumin-bound paclitaxel), has…

AbraxaneBiotechnologyCelgeneOncologyResearchSpecialised Therapeutics Australia

Brain tumor visualization drug approved in Australia

Brain tumor visualization drug approved in Australia

11-11-2013

A novel drug which assists neurosurgeons to better visualize and remove malignant brain tumors has been…

AustraliaGliolanOncologyPharmaceuticalRegulationRest of the WorldSpecialised Therapeutics Australia

Breast cancer drug Abraxane now available in New Zealand

22-02-2011

Following approval from the local regulatory authority, women in New Zealand now have access to the breast…

AbraxaneAsia-PacificCelgeneOncologyPharmaceuticalRegulationSpecialised Therapeutics Australia

Helsinn licenses anti-nausea drug Aloxi to Specialised Therapeutics for Australian and New Zealand cancer patients

02-11-2010

Lugano, Switzerland-based Helsinn has entered into an agreement with Australia’s Specialised Therapeutics…

AloxiAsia-PacificHelsinnLicensingOncologyPharmaceuticalSpecialised Therapeutics Australia

Back to top